questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines du cytosquelette
Protéines de filaments intermédiaires
Protéines de filaments intermédiaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Général
1
Intermediate Filament Proteins
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines de filaments intermédiaires : Questions médicales les plus fréquentes",
"headline": "Protéines de filaments intermédiaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines de filaments intermédiaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-03",
"dateModified": "2025-02-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines de filaments intermédiaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines du cytosquelette",
"url": "https://questionsmedicales.fr/mesh/D003598",
"about": {
"@type": "MedicalCondition",
"name": "Protéines du cytosquelette",
"code": {
"@type": "MedicalCode",
"code": "D003598",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.220"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Desmine",
"alternateName": "Desmin",
"url": "https://questionsmedicales.fr/mesh/D003893",
"about": {
"@type": "MedicalCondition",
"name": "Desmine",
"code": {
"@type": "MedicalCode",
"code": "D003893",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.220.475.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine gliofibrillaire acide",
"alternateName": "Glial Fibrillary Acidic Protein",
"url": "https://questionsmedicales.fr/mesh/D005904",
"about": {
"@type": "MedicalCondition",
"name": "Protéine gliofibrillaire acide",
"code": {
"@type": "MedicalCode",
"code": "D005904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.220.475.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Kératine-15",
"alternateName": "Keratin-15",
"url": "https://questionsmedicales.fr/mesh/D053569",
"about": {
"@type": "MedicalCondition",
"name": "Kératine-15",
"code": {
"@type": "MedicalCode",
"code": "D053569",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.220.475.450.300.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vimentine",
"alternateName": "Vimentin",
"url": "https://questionsmedicales.fr/mesh/D014746",
"about": {
"@type": "MedicalCondition",
"name": "Vimentine",
"code": {
"@type": "MedicalCode",
"code": "D014746",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.220.475.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines de filaments intermédiaires",
"alternateName": "Intermediate Filament Proteins",
"code": {
"@type": "MedicalCode",
"code": "D007381",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sarah Köster",
"url": "https://questionsmedicales.fr/author/Sarah%20K%C3%B6ster",
"affiliation": {
"@type": "Organization",
"name": "Institute for X-Ray Physics, University of Goettingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany."
}
},
{
"@type": "Person",
"name": "Sandrine Etienne-Manneville",
"url": "https://questionsmedicales.fr/author/Sandrine%20Etienne-Manneville",
"affiliation": {
"@type": "Organization",
"name": "Cell Polarity, Migration and Cancer Unit, Institut Pasteur, UMR3691 CNRS, Équipe Labellisée Ligue Contre le Cancer, F-75015 Paris, France. Electronic address: setienne@pasteur.fr."
}
},
{
"@type": "Person",
"name": "Charlotta Lorenz",
"url": "https://questionsmedicales.fr/author/Charlotta%20Lorenz",
"affiliation": {
"@type": "Organization",
"name": "Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany."
}
},
{
"@type": "Person",
"name": "Anna V Schepers",
"url": "https://questionsmedicales.fr/author/Anna%20V%20Schepers",
"affiliation": {
"@type": "Organization",
"name": "Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany."
}
},
{
"@type": "Person",
"name": "Rudolf E Leube",
"url": "https://questionsmedicales.fr/author/Rudolf%20E%20Leube",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular and Cellular Anatomy, RWTH Aachen University, Aachen, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Dosing implications for liposomal amphotericin B in pregnancy.",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36862037",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/phar.2784"
}
},
{
"@type": "ScholarlyArticle",
"name": "Amphotericin B: A drug of choice for Visceral Leishmaniasis.",
"datePublished": "2022-08-20",
"url": "https://questionsmedicales.fr/article/35998680",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.actatropica.2022.106661"
}
},
{
"@type": "ScholarlyArticle",
"name": "Post-translational modifications confer amphotericin B resistance in",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36936926",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1148681"
}
},
{
"@type": "ScholarlyArticle",
"name": "Self-Assembled Teicoplanin Micelles as Amphotericin B Nanocarrier.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36528112",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.xphs.2022.12.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Emerging Role of Sphingolipids in Amphotericin B Drug Resistance.",
"datePublished": "2023-06-15",
"url": "https://questionsmedicales.fr/article/37327022",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1089/mdr.2022.0353"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines du cytosquelette",
"item": "https://questionsmedicales.fr/mesh/D003598"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de filaments intermédiaires",
"item": "https://questionsmedicales.fr/mesh/D007381"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines de filaments intermédiaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines de filaments intermédiaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Général",
"headline": "Général sur Protéines de filaments intermédiaires",
"description": "Erreur lors de la génération.",
"url": "https://questionsmedicales.fr/mesh/D007381?mesh_terms=Amphotericin+B#section-général"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Erreur lors de la génération.",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Veuillez réessayer ultérieurement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 28/02/2025
Contenu vérifié selon les dernières recommandations médicales
9 publications dans cette catégorie
Affiliations :
Institute for X-Ray Physics, University of Goettingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.
8 publications dans cette catégorie
Affiliations :
Cell Polarity, Migration and Cancer Unit, Institut Pasteur, UMR3691 CNRS, Équipe Labellisée Ligue Contre le Cancer, F-75015 Paris, France. Electronic address: setienne@pasteur.fr.
6 publications dans cette catégorie
Affiliations :
Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.
5 publications dans cette catégorie
Affiliations :
Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.
Publications dans "Protéines de filaments intermédiaires" :
4 publications dans cette catégorie
Affiliations :
Institute of Molecular and Cellular Anatomy, RWTH Aachen University, Aachen, Germany.
Publications dans "Protéines de filaments intermédiaires" :
4 publications dans cette catégorie
Affiliations :
Max Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, D-13125 Berlin, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, D-10785 Berlin, Germany.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Dermatology, University of Michigan, Ann Arbor, MI 48109, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: coulombe@umich.edu.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Department of Mathematics, University of Manitoba, Winnipeg, MB, Canada.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Institute of Neuropathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Publications dans "Protéines de filaments intermédiaires" :
3 publications dans cette catégorie
Affiliations :
Institute for Dynamics of Complex Systems, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Protein Research, Russian Academy of Sciences, Moscow, 119334, Russia.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Institute of Protein Research, Russian Academy of Sciences, Moscow, 119334, Russia. alexminin@gmail.com.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Department of Histology and Embryology, Faculty of Veterinary Medicine, Dicle University, Diyarbakır, Turkey.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Department of Mathematics, Brigham Young University, 344 TMCB, Provo, Utah 84602-6539, USA. Electronic address: dallon@math.byu.edu.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Institut Pasteur Paris CNRS UMR3691, Cell Polarity, Migration and Cancer Unit, Equipe Labellisée Ligue Contre le Cancer, 25 rue du Dr Roux, Paris Cedex 15, 75724, France.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Turku Bioscience Centre, University of Turku and Åbo Akademi University, 20520 Turku, Finland.
Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, 20520 Turku, Finland.
Euro-Bioimaging ERIC, 20520 Turku, Finland.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Celica BIOMEDICAL, 1000 Ljubljana, Slovenia.
Department of Biochemistry and Cell Biology, Max F. Perutz Laboratories, University of Vienna, 1030 Vienna, Austria.
Publications dans "Protéines de filaments intermédiaires" :
2 publications dans cette catégorie
Affiliations :
Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Publications dans "Protéines de filaments intermédiaires" :
Liposomal amphotericin B (LAmB) is used in the treatment of opportunistic fungal and parasitic infections, including leishmaniasis. Given its lack of known teratogenicity in pregnancy, LAmB is a prefe...
Visceral leishmaniasis or Kala-azar is a vector-borne disease caused by an intracellular parasite of the genus leishmania. In India, Amphotericin B (AmB) is a first-line medication for treating leishm...
Neutropenia is a common complication in the treatment of hematological diseases and the most common predisposing factor for invasion by fungi, such as...
Teicoplanin (Teico) is an antimicrobial agent that spontaneously forms micelles in aqueous media. In this work, we characterized the physicochemical properties of nanoparticles formed by the interacti...
Invasive fungal infections in humans are common in people with compromised immune systems and are difficult to treat, resulting in high mortality. Amphotericin B (AmB) is one of the main antifungal dr...
The use of liposomal amphotericin B (L-AmB) in the treatment of cutaneous leishmaniasis (CL) is increasing. However, few data are available regarding the efficacy and safety of L-AmB in pediatric CL p...
Cutaneous leishmaniasis (CL) is the most frequent form of leishmaniasis. The auricle is an extremely rare site for CL in the Old World. Auricular CL may be mistaken for other entities, such as relapsi...
Cryptococcus neoformans is an encapsulated yeast that can cause cryptococcosis and cryptococcal meningitis, which conventional treatment involves antifungal drugs such as polyenes, flucytosine, azoles...
Pharmaceutical toxicity evaluations often use in vitro systems involving primary cells, cell lines or red blood cells (RBCs). Cell-based analyses ('bioassays') can be cumbersome and typically rely on ...
Biofilm formation causes virulence and resistance in Candida albicans. However, little is known about breakthrough candidemia isolates. We evaluated the antifungal activity of fluconazole, anidulafung...
The present study used strains of C. albicans isolated from breakthrough and non-breakthrough candidemia patients (control group). The susceptibility of planktonic cells to amphotericin B, anidulafung...
The planktonic strains were susceptible to amphotericin B, anidulafungin, and fluconazole, with minimum inhibitory concentrations of 1, ≤0.03, and 2mg/L, respectively. However, fluconazole and anidula...
In the present study, only dAMB and ABCL exhibited antibiofilm effects against sessile breakthrough candidemia isolates....